• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠还是非新冠:社区队列中死亡原因的归因和报告。

COVID or not COVID: attributing and reporting cause of death in a community cohort.

机构信息

Regensburg Department of Public Health, Altmühlstr. 3, 93059, Regensburg, Germany; Department of Epidemiology and Preventive Medicine, Faculty of Medicine, University of Regensburg, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.

Regensburg Department of Public Health, Altmühlstr. 3, 93059, Regensburg, Germany.

出版信息

Public Health. 2022 Apr;205:157-163. doi: 10.1016/j.puhe.2022.02.008. Epub 2022 Mar 11.

DOI:10.1016/j.puhe.2022.02.008
PMID:35287022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8916663/
Abstract

OBJECTIVES

In Germany, deaths of SARS-CoV-2-positive persons are reported as 'death related to SARS-CoV-2/COVID-19' to the Robert Koch Institute, Germany's main infectious disease institution. In 177 COVID-19-associated deaths reported in Regensburg, Germany, from October 2020 to January 2021, we investigated how deaths following SARS-CoV-2 infection were reported and whether cases with a death attributed to SARS-CoV-2 (COVID-19 death [CD]) differed from cases with a reported death from other causes (non-COVID-19 death [NCD]).

STUDY DESIGN

This was an observational retrospective cohort study.

METHODS

We analysed descriptive data on the numbers of cases, deaths, age, sex, symptoms and hospitalizations. We calculated odds ratios (ORs) with 95% confidence intervals (95% CIs) and performed Chi-squared/Fisher's exact test for categorical variables and the Wilcoxon rank-sum test for comparison of medians.

RESULTS

Deaths attributed to COVID-19 occurred primarily in elderly patients. The mortality rate and the case fatality ratio (CFR) increased with age. The median age and the prevalence of risk factors were similar between CD and NCD. Respiratory symptoms and pneumonia at the time of diagnosis were associated with death reported as CD. The odds of CD attribution in cases hospitalized because of COVID-19 were 6-fold higher than the odds of NCD (OR: 6.00; 95% CI: 1.32 to 27.22).

CONCLUSIONS

Respiratory symptoms/pneumonia at the time of diagnosis and hospitalization due to COVID-19 were associated with attributing a death to COVID-19. Numbers of COVID deaths need to be interpreted with caution. Criteria that facilitate attributing the cause of death among SARS-CoV-2 cases more uniformly could make these figures more comparable.

摘要

目的

在德国,罗伯特·科赫研究所(德国主要传染病机构)将 SARS-CoV-2 阳性者的死亡报告为“与 SARS-CoV-2/COVID-19 相关的死亡”。在德国雷根斯堡 2020 年 10 月至 2021 年 1 月期间报告的 177 例与 COVID-19 相关的死亡中,我们调查了 SARS-CoV-2 感染后的死亡报告方式,以及归因于 SARS-CoV-2 的病例(COVID-19 死亡[CD])与报告其他原因死亡的病例(非 COVID-19 死亡[NCD])是否存在差异。

研究设计

这是一项观察性回顾性队列研究。

方法

我们分析了病例数量、死亡人数、年龄、性别、症状和住院情况的描述性数据。我们计算了比值比(OR)及其 95%置信区间(95%CI),并使用卡方/Fisher 精确检验进行分类变量分析,使用 Wilcoxon 秩和检验进行中位数比较。

结果

COVID-19 死亡主要发生在老年患者中。死亡率和病死率(CFR)随年龄增长而增加。CD 和 NCD 之间的中位年龄和危险因素的患病率相似。诊断时的呼吸道症状和肺炎与报告为 CD 的死亡相关。因 COVID-19 住院的病例归因于 CD 的几率是非 COVID-19 死亡的 6 倍(OR:6.00;95%CI:1.32 至 27.22)。

结论

诊断时的呼吸道症状/肺炎和因 COVID-19 住院与归因于 COVID-19 死亡相关。COVID 死亡人数需要谨慎解读。有助于更均匀地归因于 SARS-CoV-2 病例死因的标准可以使这些数据更具可比性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/808b/8916663/917ba6fbeb74/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/808b/8916663/297268a3bd6c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/808b/8916663/7cef3cb884a1/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/808b/8916663/917ba6fbeb74/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/808b/8916663/297268a3bd6c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/808b/8916663/7cef3cb884a1/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/808b/8916663/917ba6fbeb74/gr3_lrg.jpg

相似文献

1
COVID or not COVID: attributing and reporting cause of death in a community cohort.新冠还是非新冠:社区队列中死亡原因的归因和报告。
Public Health. 2022 Apr;205:157-163. doi: 10.1016/j.puhe.2022.02.008. Epub 2022 Mar 11.
2
COVID-19-related deaths: a 2-year inter-wave comparison of mortality data from Germany.COVID-19 相关死亡:德国两波疫情间死亡率数据的对比分析。
Infection. 2023 Aug;51(4):1147-1152. doi: 10.1007/s15010-023-01982-4. Epub 2023 Jan 24.
3
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
4
Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany.死于 SARS-CoV-2 感染——德国汉堡首例连续 80 例尸检研究。
Int J Legal Med. 2020 Jul;134(4):1275-1284. doi: 10.1007/s00414-020-02317-w. Epub 2020 Jun 4.
5
Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study.成人因冠状病毒 19 住院和死亡风险的生存风险预测算法(QCOVID):全国推导和验证队列研究。
BMJ. 2020 Oct 20;371:m3731. doi: 10.1136/bmj.m3731.
6
Characteristics of cases and deaths arising from SARS-CoV-2 infection in Zambia: March 2020 to April 2021.赞比亚 2020 年 3 月至 2021 年 4 月期间 SARS-CoV-2 感染所致病例和死亡的特征。
Pan Afr Med J. 2023 Aug 10;45:155. doi: 10.11604/pamj.2023.45.155.32018. eCollection 2023.
7
Factors Associated with a Positive Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Suspected Cases Presenting with Pneumonia: A Retrospective Cohort Study in a Single Medical Center.与疑似肺炎患者 SARS-CoV-2 检测呈阳性相关的因素:单中心回顾性队列研究。
Respiration. 2020;99(9):739-747. doi: 10.1159/000508398. Epub 2020 Nov 18.
8
Characterizing a two-pronged epidemic in Mexico of non-communicable diseases and SARS-Cov-2: factors associated with increased case-fatality rates.解析墨西哥非传染性疾病和新冠病毒的双重疫情:与病死率上升相关的因素
Int J Epidemiol. 2021 May 17;50(2):430-445. doi: 10.1093/ije/dyab008.
9
SARS-CoV-2 Infection Hospitalization Rate and Infection Fatality Rate Among the Non-Congregate Population in Connecticut.康涅狄格州非群居人群中的 SARS-CoV-2 感染住院率和感染病死率。
Am J Med. 2021 Jun;134(6):812-816.e2. doi: 10.1016/j.amjmed.2021.01.020. Epub 2021 Feb 20.
10
Increased Risk of Hospitalization and Death in Patients with COVID-19 and Pre-existing Noncommunicable Diseases and Modifiable Risk Factors in Mexico.墨西哥患有 COVID-19 及既往非传染性疾病和可改变的危险因素的患者住院和死亡风险增加。
Arch Med Res. 2020 Oct;51(7):683-689. doi: 10.1016/j.arcmed.2020.07.003. Epub 2020 Jul 22.

引用本文的文献

1
To test or not to test? A new behavioral epidemiology framework for COVID-19.检测还是不检测?一种针对新冠病毒病的行为流行病学新框架。
PLoS One. 2024 Dec 17;19(12):e0309423. doi: 10.1371/journal.pone.0309423. eCollection 2024.
2
China's policies: post-COVID-19 challenges for the older population.中国的政策:后新冠疫情时代对老年人口的挑战。
Glob Health Action. 2024 Dec 31;17(1):2345968. doi: 10.1080/16549716.2024.2345968. Epub 2024 May 8.
3
Differentiating patients admitted primarily due to coronavirus disease 2019 (COVID-19) from those admitted with incidentally detected severe acute respiratory syndrome corona-virus type 2 (SARS-CoV-2) at hospital admission: A cohort analysis of German hospital records.

本文引用的文献

1
Clinical and epidemiological data of COVID-19 from Regensburg, Germany: a retrospective analysis of 1084 consecutive cases.德国雷根斯堡的 COVID-19 的临床和流行病学数据:1084 例连续病例的回顾性分析。
Infection. 2021 Aug;49(4):661-669. doi: 10.1007/s15010-021-01580-2. Epub 2021 Mar 5.
2
[COVID-19-associated deaths].[与COVID-19相关的死亡]
Rechtsmedizin (Berl). 2021;31(5):408-417. doi: 10.1007/s00194-021-00455-y. Epub 2021 Feb 15.
3
Causes of death and comorbidities in hospitalized patients with COVID-19.COVID-19 住院患者的死亡原因和合并症。
在医院入院时区分主要因 2019 年冠状病毒病(COVID-19)而入院的患者和因偶然发现的严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)而入院的患者:德国医院记录的队列分析。
Infect Control Hosp Epidemiol. 2024 Jun;45(6):746-753. doi: 10.1017/ice.2024.3. Epub 2024 Feb 14.
4
Regional clustering and waves patterns due to COVID-19 by the index virus and the lambda/gamma, and delta/omicron SARS-CoV-2 variants in Peru.秘鲁因新冠病毒指数毒株以及拉姆达/伽马、德尔塔/奥密克戎新冠病毒变异株导致的COVID-19区域聚集和波型。
Gates Open Res. 2023 Nov 20;6:74. doi: 10.12688/gatesopenres.13644.2. eCollection 2022.
5
Effects of social factors on the COVID-19 cases and its evolution in Hubei, China.社会因素对中国湖北省 COVID-19 病例及其演变的影响。
Front Public Health. 2023 Jun 16;11:1124541. doi: 10.3389/fpubh.2023.1124541. eCollection 2023.
6
Risk factors for deaths associated with COVID-19 according to the cause of death classification in Republic of Korea.根据韩国死因分类,与2019冠状病毒病相关的死亡风险因素。
Osong Public Health Res Perspect. 2023 Apr;14(2):89-99. doi: 10.24171/j.phrp.2022.0312. Epub 2023 Apr 18.
7
Expectations of non-COVID-19 deaths during the pre-vaccine pandemic: a process-control approach.大流行前疫苗时代对非 COVID-19 死亡的预期:一种过程控制方法。
BMC Public Health. 2023 Jan 23;23(1):155. doi: 10.1186/s12889-022-14829-8.
8
COVID-19-related deaths: a 2-year inter-wave comparison of mortality data from Germany.COVID-19 相关死亡:德国两波疫情间死亡率数据的对比分析。
Infection. 2023 Aug;51(4):1147-1152. doi: 10.1007/s15010-023-01982-4. Epub 2023 Jan 24.
Sci Rep. 2021 Feb 19;11(1):4263. doi: 10.1038/s41598-021-82862-5.
4
Age, Multiple Chronic Conditions, and COVID-19: A Literature Review.年龄、多种慢性疾病与 COVID-19:文献回顾。
J Gerontol A Biol Sci Med Sci. 2022 Apr 1;77(4):872-878. doi: 10.1093/gerona/glaa320.
5
COVID-19 case-fatality rate and demographic and socioeconomic influencers: worldwide spatial regression analysis based on country-level data.COVID-19 病死率及其人口统计学和社会经济影响因素:基于国家级数据的全球空间回归分析。
BMJ Open. 2020 Nov 3;10(11):e043560. doi: 10.1136/bmjopen-2020-043560.
6
Age-specific mortality and immunity patterns of SARS-CoV-2.SARS-CoV-2 的年龄特异性死亡率和免疫模式。
Nature. 2021 Feb;590(7844):140-145. doi: 10.1038/s41586-020-2918-0. Epub 2020 Nov 2.
7
A Study on the Predictors of Disease Severity of COVID-19.一项关于 COVID-19 疾病严重程度预测因素的研究。
Med Sci Monit. 2020 Sep 23;26:e927167. doi: 10.12659/MSM.927167.
8
Understanding the epidemiology, pathophysiology, diagnosis and management of SARS-CoV-2.了解严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的流行病学、病理生理学、诊断及管理。
J Int Med Res. 2020 Aug;48(8):300060520949077. doi: 10.1177/0300060520949077.
9
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain.西班牙 4035 例连续住院 COVID-19 患者的死亡特征和预测因素。
Clin Microbiol Infect. 2020 Nov;26(11):1525-1536. doi: 10.1016/j.cmi.2020.07.024. Epub 2020 Aug 4.
10
Dying 'due to' or 'with' COVID-19: a cause of death analysis in hospitalised patients.因 COVID-19 而死亡或与 COVID-19 共同导致死亡:住院患者死因分析。
Clin Med (Lond). 2020 Sep;20(5):e189-e190. doi: 10.7861/clinmed.2020-0440. Epub 2020 Aug 3.